Tag: 269-patients
-
J&J leukemia drug cuts death risk vs. chemo in new patients: study
Johnson & Johnson’s and AbbVie’s cancer drug Imbruvica significantly reduced the risk of death and disease progression compared with chemotherapy in previously untreated patients with a type of leukemia in a late stage study, paving the way for an expanded approval of the medicine. In the trial of 269 patients aged 65 and older with…
-
Novartis trial shows drug improves survival for AML patients
ZURICH (Reuters) – Novartis' phase III study for its acute myeloid leukemia (AML) drug showed it improved overall survival by 23 percent for patients with FLT3 mutations, the Swiss drugmaker said on Sunday. Basel-based Novartis said the study was the first large controlled trial to show overall survival benefit in FLT3-mutated AML, and that worldwide…
-
VW denies Qatar talks sought to curb labor role
Volkswagen has denied a report saying its chief executive and chairman were urged on Sunday by its third-largest shareholder to reduce the influence of VW's powerful unions as it battles to overcome its emissions scandal. CEO Matthias Mueller and Chairman Hans Dieter Poetsch met with leaders of the Qatar Investment Authority (QIA) in Doha on…
-
Red Cross talks to debate new mechanism for upholding laws of war
By Stephanie Nebehay GENEVA (Reuters) – States are divided about an attempt to improve compliance with the rules of war, a non-binding but contentious issue at the heart of an international conference next week, senior Swiss and Red Cross officials say. The Dec. 8-10 meeting will consider a resolution to hold an annual meeting of…